BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7776898)

  • 1. The 'LXCXE' hydropathic superfamily of ligands for retinoblastoma protein: a proposal.
    Radulescu RT
    Med Hypotheses; 1995 Jan; 44(1):28-31. PubMed ID: 7776898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular determinants for the complex formation between the retinoblastoma protein and LXCXE sequences.
    Singh M; Krajewski M; Mikolajka A; Holak TA
    J Biol Chem; 2005 Nov; 280(45):37868-76. PubMed ID: 16118215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7.
    Lee JO; Russo AA; Pavletich NP
    Nature; 1998 Feb; 391(6670):859-65. PubMed ID: 9495340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of the LXCXE insulin motif to a hexapeptide derived from retinoblastoma protein.
    Radulescu RT; Bellitti MR; Ruvo M; Cassani G; Fassina G
    Biochem Biophys Res Commun; 1995 Jan; 206(1):97-102. PubMed ID: 7818556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural principles in cell-cycle control: beyond the CDKs.
    Endicott JA; Noble ME
    Structure; 1998 May; 6(5):535-41. PubMed ID: 9634691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cyclin box fold: protein recognition in cell-cycle and transcription control.
    Noble ME; Endicott JA; Brown NR; Johnson LN
    Trends Biochem Sci; 1997 Dec; 22(12):482-7. PubMed ID: 9433129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folding of a cyclin box: linking multitarget binding to marginal stability, oligomerization, and aggregation of the retinoblastoma tumor suppressor AB pocket domain.
    Chemes LB; Noval MG; Sánchez IE; de Prat-Gay G
    J Biol Chem; 2013 Jun; 288(26):18923-38. PubMed ID: 23632018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposed interaction between insulin and retinoblastoma protein.
    Radulescu RT; Wendtner CM
    J Mol Recognit; 1992 Dec; 5(4):132-7. PubMed ID: 1339481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Death-defying pathways linking cell cycle and apoptosis.
    Kirshenbaum LA
    Circ Res; 2001 May; 88(10):978-80. PubMed ID: 11375264
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence for a protein domain superfamily shared by the cyclins, TFIIB and RB/p107.
    Gibson TJ; Thompson JD; Blocker A; Kouzarides T
    Nucleic Acids Res; 1994 Mar; 22(6):946-52. PubMed ID: 8152925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.
    Helt AM; Galloway DA
    J Virol; 2001 Aug; 75(15):6737-47. PubMed ID: 11435552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the Rb--Raf-1 interaction inhibits tumor growth and angiogenesis.
    Dasgupta P; Sun J; Wang S; Fusaro G; Betts V; Padmanabhan J; Sebti SM; Chellappan SP
    Mol Cell Biol; 2004 Nov; 24(21):9527-41. PubMed ID: 15485920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of retinoblastoma protein function by coexpression of its C pocket fragment.
    Welch PJ; Wang JY
    Genes Dev; 1995 Jan; 9(1):31-46. PubMed ID: 7828850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein.
    Wang CY; Petryniak B; Thompson CB; Kaelin WG; Leiden JM
    Science; 1993 May; 260(5112):1330-5. PubMed ID: 8493578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of homologous binding sites on RB and p107 common for viral oncoproteins and cellular ligands.
    Wendtner CM; Radulescu RT
    J Mol Recognit; 1992 Dec; 5(4):125-32. PubMed ID: 1339480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.
    Nevins JR
    Science; 1992 Oct; 258(5081):424-9. PubMed ID: 1411535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.
    Ledl A; Schmidt D; Müller S
    Oncogene; 2005 May; 24(23):3810-8. PubMed ID: 15806172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins.
    Ewen ME; Faha B; Harlow E; Livingston DM
    Science; 1992 Jan; 255(5040):85-7. PubMed ID: 1532457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
    Rubin SM; Gall AL; Zheng N; Pavletich NP
    Cell; 2005 Dec; 123(6):1093-106. PubMed ID: 16360038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability.
    Woitach JT; Zhang M; Niu CH; Thorgeirsson SS
    Nat Genet; 1998 Aug; 19(4):371-4. PubMed ID: 9697699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.